Skip to main content

Berg, U of Miami Extend Cardiovascular Disease Collaboration

NEW YORK (GenomeWeb) – Bioinformatics firm Berg said today that it is extending an ongoing collaboration with the University of Miami's Leonard M. Miller School of Medicine aimed at better understanding cardiovascular disease, identifying new biomarkers, and developing new treatments.

As part of the partnership, theUniversityofMiamiwill provide Berg access to clinical tissue samples obtained with patients' consent from its Miller School of Medicine. According to the collaborators, this is the first time theUniversityofMiamihas given a private research company access to these samples.

Berg will then use its Interrogative Biology platform to analyze the tissues in an effort to uncover novel biomarkers for the prevention of cardiac dysfunction and heart failure.

"This will enable stratification of patients based on disease onset and progression, and facilitate timely clinical intervention to improve patient outcomes," Rangaprasad Sarangarajan, chief scientific officer and co-founder of Berg Biosystems, said in a statement.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.